Association of Menopausal Status with Thyroid Nodule Prevalence and Size in Women with Hypothyroidism

Authors

Berkan Acar, Ali Muhtaroğlu, Kubilay İşsever, Sefer Aslan, Ersin Kuloğlu, Mehmet Yıldız, Elif Yılmaz
https://doi.org/10.18621/eurj.1275

Objective: To examine the association between menopausal status and thyroid nodule prevalence and size in women with hypothyroidism.

Methods: In this retrospective comparative study, we reviewed 149 women with hypothyroidism seen in outpatient clinics at a tertiary care hospital. Hypothyroidism was defined as a documented clinical diagnosis supported by elevated thyroid-stimulating hormone (TSH) with low or normal thyroxine (T4). Women were classified as being in the reproductive period or postmenopausal; postmenopause was defined as amenorrhoea for at least 12 months or documented postmenopausal status in the medical record. Group comparisons used the chi-square test, independent-samples t-test, or Mann-Whitney U test, as appropriate. Crude ORs with 95% CIs were calculated for key dichotomous nodule outcomes.

Results: Of the 149 women, 89 (59.7%) were of reproductive age, and 60 (40.3%) were postmenopausal. Thyroid nodules were present in 61 (40.9%) patients. Postmenopausal women had a higher prevalence of nodules than reproductive-age women (56.7% vs 30.3%; crude OR, 3.00; 95% CI, 1.52–5.94; P=0.002). Nodules >1 cm were also more frequent after menopause (25.0% vs. 9.0%; crude OR, 3.38; 95% CI, 1.33–8.57; P=0.029). TSH, T4, anti-thyroid peroxidase (anti-TPO) levels, anti-TPO positivity, and levothyroxine use did not differ significantly between the groups.

Conclusion: Among women with hypothyroidism, postmenopausal status was associated with a greater thyroid nodule burden and a higher frequency of nodules >1 cm. Because age and menopausal status were closely linked, the findings should be interpreted as unadjusted associations rather than independent effects of menopause.

Hypothyroidism, Menopausal Status, Postmenopause, Thyroid Nodule, Thyroid Ultrasonography, Reproductive Age

1. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022;8(1):30. doi: 10.1038/s41572-022-00357-7.

2. Bogusławska J, Godlewska M, Gajda E, Piekiełko-Witkowska A. Cellular and molecular basis of thyroid autoimmunity. Eur Thyroid J. 2022;11(1):e210024. doi: 10.1530/ETJ-21-0024.

3. Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. 2023;12(5):e230067. doi: 10.1530/ETJ-23-0067.

4. Brown EDL, Obeng-Gyasi B, Hall JE, Shekhar S. The thyroid hormone axis and female reproduction. Int J Mol Sci. 2023;24(12):9815. doi: 10.3390/ijms24129815.

5. Mintziori G, Veneti S, Poppe K, et al. EMAS position statement: Thyroid disease and menopause. Maturitas. 2024;185:107991. doi: 10.1016/j.maturitas.2024.107991.

6. Kesibi D, Rotondi M, Edgell H, Tamim H. Associations between age at natural menopause and risk of hypothyroidism among postmenopausal women from the Canadian Longitudinal Study on Aging (CLSA). PLoS One. 2025;20(5):e0324635. doi: 10.1371/journal.pone.0324635.

7. Yadav M, Kose V, Bhalerao A. Frequency of thyroid disorder in pre- and postmenopausal women and its association with menopausal symptoms. Cureus. 2023;15(6):e40900. doi: 10.7759/cureus.40900.

8. Capozzi A, Scambia G, Lello S. Subclinical hypothyroidism in women’s health: from pre- to post-menopause. Gynecol Endocrinol. 2022;38(5):357-367. doi: 10.1080/09513590.2022.2046728.

9. Xu J, Lau P, Ma Y, et al. Prevalence and associated factors of thyroid nodules among 52,003 Chinese healthy individuals in Beijing: a retrospective cross-sectional study. Risk Manag Healthc Policy. 2024;17:181-189. doi: 10.2147/RMHP.S442062.

10. Xie H, Pan H, Qian T, et al. Analysis of factors influencing prevalence and malignancy of thyroid nodules in various iodine uptake areas. Front Endocrinol (Lausanne). 2024;15:1451911. doi: 10.3389/fendo.2024.1451911.

11. Iuliano S, Mirabelli M, Giuliano S, Brunetti A. Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer. Curr Opin Oncol. 2026;38(1):1-10. doi: 10.1097/CCO.0000000000001202.

12. Yu H, Cao J, Han J, et al. Risk factors for thyroid nodules in a health examination population: a cross-sectional study and development of a simplified predictive model. Front Endocrinol (Lausanne). 2026;16:1738544. doi: 10.3389/fendo.2025.1738544.

13. El Aghoury A, Abd ElHafeez S, El Sabaa B, et al. Hashimoto’s thyroiditis in an Egyptian cohort: clinical, functional, and ultrasonographic features with insights into nodule risk. Front Endocrinol (Lausanne). 2025;16:1664047. doi: 10.3389/fendo.2025.1664047.

14. Wang P, Zhang H, Wang J, et al. Metabolic disease and risk of thyroid disease: evidence from the National Nurse Health Cohort in China. Biol Res Nurs. 2023;25(4):627-634. doi: 10.1177/10998004231177297.

There are 14 references in total.
1.
Acar B, Muhtaroğlu A, İşsever K, et al. Association of Menopausal Status with Thyroid Nodule Prevalence and Size in Women with Hypothyroidism. Eur Res J. Published online July 5, 2026:1-8. doi:10.18621/eurj.1275

Downloads

Article Information

All data generated or analyzed during this study are included in this published article. The data that support the findings of this study are available on request from the corresponding author, upon reasonable request.

  • File Downloads 0
  • Abstract Views 0
  • Altmetrics
  • Share
Download data is not yet available.